James has been involved in commercialising early stage technologies over a period of 20 years, in biotech, academia and clinical settings. He has experience in biotech IP, raising seed and series A funding and more recently in late stage product development. James joined Cambridge Consultants in 2016 and is leading on providing custom services and hardware to synbio companies.